Skip to main content

TEVA 8231 TEVA 8231 Pill - brown capsule-shape, 18mm

Pill with imprint TEVA 8231 TEVA 8231 is Brown, Capsule-shape and has been identified as Sunitinib Malate 50 mg. It is supplied by Teva Pharmaceuticals USA, Inc.

Sunitinib is used in the treatment of gastrointestinal stromal tumor; pancreatic cancer; renal cell carcinoma and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 50 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for TEVA 8231 TEVA 8231

Sunitinib malate 50 mg TEVA 8231 TEVA 8231

Sunitinib Malate

TEVA 8231 TEVA 8231
50 mg
18.00 mm
Prescription only
Drug Class
Multikinase inhibitors, VEGF/VEGFR inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA, Inc.
National Drug Code (NDC)
Inactive Ingredients
croscarmellose sodium, magnesium stearate, mannitol, povidone k30, FD&C Blue No. 1, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, titanium dioxide, ferrosoferric oxide, D&C Yellow No. 10 Aluminium Lake, FD&C Blue No. 1 Aluminium Lake, FD&C Blue No. 2 Aluminium Lake, shellac, propylene glycol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.